Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
Rhea-AI Summary
Co-Diagnostics (Nasdaq: CODX) will release its first quarter 2026 financial results on Thursday, May 14, 2026 after market close. A live conference call and webcast will follow at 4:30 p.m. ET with CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson.
The webcast will be available at ir.co-dx.com on the Events & Webcasts page; a recorded replay will be posted later.
Positive
- None.
Negative
- None.
News Market Reaction – CODX
On the day this news was published, CODX gained 1.31%, reflecting a mild positive market reaction. This price movement added approximately $77K to the company's valuation, bringing the market cap to $5.94M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Scanner data shows mixed peer moves: NXL up 7.52%, SINT up 10.37%, and NVNO down 3.27%. With no clear, shared direction and CODX’s move treated separately, this points to stock-specific dynamics rather than a coordinated sector rotation around the earnings date announcement.
Previous Earnings date Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 17 | Earnings date notice | Neutral | -8.4% | Announcement of Q4 and full year 2025 earnings release date and webcast. |
| Apr 30 | Earnings date notice | Neutral | +0.0% | Announcement of Q1 2026 earnings release date and investor webcast details. |
The prior earnings date announcement coincided with a negative -8.4% move, suggesting the market has previously reacted cautiously to simple scheduling updates.
In recent months, CODX has reported sharply weaker 2025 results, with revenue down and significant operating losses, alongside going-concern warnings in its 10-K. Operational updates highlighted regulatory progress and joint ventures in India and Saudi Arabia, plus conference participation to showcase its PCR platform, which remains under regulatory review. Against this backdrop, the current Q1 2026 earnings date notice continues a pattern of routine investor communications following substantive financial disclosures.
Historical Comparison
Past earnings-date news for CODX saw an average -8.4% move, indicating that even routine scheduling updates have previously coincided with notable downside volatility.
The company has issued repeated earnings date notices with similar webcast formats, following major financial result announcements and maintaining consistent communication practices.
Market Pulse Summary
This announcement sets expectations for Co-Diagnostics’ Q1 2026 earnings release on May 14, 2026 and details an investor webcast at 4:30 p.m. ET. In the months prior, filings highlighted sharp 2025 losses, reduced cash, and going-concern warnings, alongside ongoing regulatory efforts for its PCR platform. Investors may focus on upcoming revenue trends, cash levels, and regulatory milestones when the full results are reported.
Key Terms
molecular diagnostics medical
AI-generated analysis. Not financial advice.
The conference call and webcast will be available via:
Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here
Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-announces-first-quarter-2026-earnings-release-date-and-webcast-302758752.html
SOURCE Co-Diagnostics